Fritextsökning
Innehållstyper
-
Nya data från Alligator
Alligator bioscience presenterar nya prekliniska data för kandidaten ATOR-1144.
-
640 miljoner till forskningsprojekt
Knut och Alice Wallenbergs Stiftelse har beviljat totalt 640 miljoner kronor till 22 forskningsprojekt varav flera inom medicin som bedöms ha möjlighet att leda...
-
Changing e-solutions for clinical trials
Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming...
-
New head of Vinnova
While waiting for a new gerenal-director, Vinnova has got a substitute general-director.
-
View pathology images in your iPhone
The Institute for Medical Informatics in Oslo announces a brand new iPhone application for virtual microscopy.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Hey Kurt Berndt...
... who is starting up a research center for youths in Saltsjöbaden.
-
Novavax utvecklar coronavaccin
Inom ett och ett halvt år kan ett vaccin mot det nya coronaviruset vara tillgängligt. Det har redan visat lovande resultat i djurstudier. – Vi har möjlighet att...
-
Ny antibiotikaklass når fas III
Ska utvärderas i två studier som behandling av urinvägsinfektion och gonorré.
-
Density meters with six-digit precision
The new instruments from Krüss Optronic offer high sensitivity for density measurements.
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
A+Science söker vd
Göran Wessman lämnar sitt uppdrag. Bolagets operativa chef kliver in som tillförordnad vd medan rekrytering pågår.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
BMAs: Run your own business
After graduation you must decide: be an employee or start your own business. This is not really the situation for BMAs today, but a collaborative project betwee...
-
Ny modell ska identifiera rätt dos litium vid bipolär sjukdom
Ny forskning vid Karolinska institutet kan bidra till att lösa ett stort problem inom behandling av bipolär sjukdom: att hitta rätt dos litium för varje patient.
-
Rapid system for surface hygiene monitoring
The Clean-Trace Surface Testing Instruments are a rapid solution to monitor biological contamination on surfaces in real time to help customers manage their cle...
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
Vaccin mot borrelia kan bli verklighet
Franska Valneva, med tillverkning i Sverige, och amerikanska Pfizer inleder en fas III-studie med ett vaccin mot borrelia. Studien startar redan i år.
-
With their hands on the legal levers
It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.
-
Ny topp till Vetenskapsakademien
Professor Dan Larhammar har valts till ny preses av Kungl. Vetenskapsakademien – ett av målen är att folkbilda och att synas i samhällsdebatten.
-
Focusing on Medicon Valley
Copenhagen Capacity and Invest in Skåne are hosting a seminar to promote the geographical area known as Medicon Valley. Some of the 350 life science companies f...